Beximco Pharma is first Bangladeshi company to receive GMP Clearance from TGA Australia
Beximco Pharmaceuticals Ltd. (“BPL” or the “Company”), the leading Bangladeshi pharmaceutical manufacturer and exporter, is pleased to announce that it has received approval (GMP Clearance) from Therapeutic Goods Administration (TGA), Australia for its new Oral Solid Dosage (Tablet, Capsule), and the Metered Dose Inhaler and Spray manufacturing facilities. BPL is the first Bangladeshi company to receive this regulatory approval from TGA, Australia through a stringent facility audit process.

The Thirty-Second Annual General Meeting
Notice is hereby given that the THIRTY-SECOND ANNUAL GENERAL MEETING of the Shareholders of Beximco Pharmaceuticals Limited will be held on Thursday, the 21st August, 2008 at 10.30 a.m. at 1, Shahbag C/A, Dhaka to transact the following business :

Beximco Pharma awards Merit Scholarships
Beximco Pharmaceuticals Ltd. (“BPL” or the “Company”), the leading pharmaceutical manufacturer and exporter of Bangladesh, launched a ‘Merit Scholarship Scheme’ for the children of its factory employees, a company statement said today

Beximco Pharmaceuticals Limited, a leading manufacturer of generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids in Bangladesh, today issues a trading update prior to the end of its financial year on 31 December 2005.More

Beximco Pharmaceuticals Ltd (BPL) has received "SAARC Country Gold Award-2005" from Sri Lanka's premier chamber, Ceylon National Chamber of Industries (CNCI). Mr. Nazmul Hassan, Chief Executive Officer of Beximco Pharmaceuticals Ltd., received the award from Mr. Macky Hasim, President of the SAARC Chamber of Commerce & Industry More

Cardiff hero Mohammad Ashraful who scored the defiant hundred for Bangladesh against world champions Australia will be honoured by Beximco Pharmaceuticals in a move that will also recognise fellow Tigers in the victorious team. More

In an ambitious expansion scheme, a top Beximco company today (Thursday) unveiled plans to raise UK £ 27 million - nearly 315 crore taka - through an instrument called global depository receipt (GDR) from the United Kingdom . The stock is ready for launch next month. More

The High Court today (May 2, 2005) directed Beximco Pharmaceuticals and Beximco Infusions to hold an extra-ordinary general meeting (EGM) on June 2, 2005 to get approval of their shareholders for an ambitious 'amalgamation scheme'. More

Beximco Pharma Ltd. (BPL) and Dutch Bangla Bank Ltd. (DBBL) signed an agreement on 18th April, 2005 under which BPL would supply ARV (Anti Retro Viral) drugs to DBBL for 23 AIDS patient of Bangladesh. More

A colorful launching program of 'Bextram Gold' a high potency multivitamin and multimineral tablet was held at the Bangladesh-China Friendship Conference Center yesterday.Renowned Pharmaceutical Company BPL starts marketing this vitamin. More

A scientific seminar on "Management of Diabetes" was held at Dhaka Sheraton Hotel. Beximco Pharma organized the seminar in connection with formal launching of their new antidiabetic drug 'Informet LA'. More

Breast cancer is one of the most deadly disease of women. The incidence of breast cancer is increasing now a days in our country. More

A scientific seminar titled 'HIV Situation in Bangladesh: Role of Healthcare Providers' was held at Bangladesh-China Friendship Conference Center on 25th October, 2003.BP L organized the seminar in connection with their formal lunching of five anti-AIDS drugs for the first time in Bangladesh. More

A scientific seminar on "Recent advances in pain management" was held at Bangladesh-China Friendship Conference Center on 24th September (Friday).Beximco Pharma organized the seminar in connection with formal launching of their new drug 'Ultrafen Plus'. Prof. Sirajuddin Ahmed More